RE: risk/reward11 Nov 2022 07:54
Why is everyone ignoring this?
"Potential Distribution Agreement
We have agreed to explore the opportunity of a mutually beneficial route to allow ImmuPharma to introduce certain Avion products into the European market. If this is successful, this would generate top-line product sales revenue for the first time in ImmuPharma's history and contribute net positive cash flow to the Company.
We in turn, have identified an established European partner who could provide the infrastructure to market and distribute the products.
Discussions are to be progressed as to the legal, regulatory and commercial aspects of such a collaboration and we will provide further details in due course."